Magnesium Sulfate In Water Injection
Product Images NDC 44567-421

This is a description of a medication with NDC number 44567-421-24, which has a volume of 100 mL. The medication contains Magnesium Sulfate and 4 parts of Water for Injection with a concentration of 0.325 mEq Mg*/mL and 40 mg/mL.*

This is a prescription-only intravenous infusion solution that contains 20g magnesium sulfate heptahydrate in water for injection. It is sterile, nonpyrogenic, and the usual dose should be reviewed through the package insert. The solution has a pH of 4.5 and may contain sulfuric acid and/or sodium hydroxide for pH adjustment. It should not be used with any supplementary medication and should only be administered through the central route. This is a single-dose container and any unused portion should be discarded. The solution must not be used in series connections and should be stored at 20°C to 25°C (68°F to 77°F), protected from freezing. The manufacturer is WG Critical Care, LLC and the product is made in Switzerland.*

This is a description of a sterile and non-pyrogenic intravenous infusion solution consisting of Magnesium Sulfate (in Water for Injection) with NDC code 44567-423-10. It comes in a single-use container with a total volume of 1000 mL containing 40 g of magnesium sulfate heptahydrate, which is equivalent to 325 mEq of magnesium. The solution may contain sulfuric acid and/or sodium hydroxide for pH adjustment. The recommended pH range is between 3.5 to 6.5. The solution is not mixed with supplementary medication and should be used through a central route when possible. The solution must be used promptly when the pouch is opened and the solution is clear and not damaged. It should be stored at a temperature between 20 to 25°C and should not be frozen. The manufacturer of the solution is WG Critical Care, LLC located in Paramus, NJ 07652, and it was made in Switzerland. There is no information on the usual dose as it is mentioned to refer to the package insert.*

This is a description of a drug named Magnesium Sulfate which is used for Intravenous Infusion purposes only. It comes in a 50 mL single-dose container and contains Magnesium Sulfate heptahydrate, equivalent to 16.25 mEq of Magnesium. The package may include sulfuric acid and/or sodium hydroxide for pH adjustment. It must be used only if the solution is clear, and the container is undamaged. It should not be used in series connections, and the unused portion must be discarded. The usual dosage should be followed as per the package insert, and it must be stored at 20°C to 25°C. The drug is sterile, nonpyrogenic, and manufactured by WG Critical Care, LLC, Paramus, USA. The drug is made in Switzerland, and the revision date for the package is September 2018.*

This is a description of Magnesium Sulfate injection solution which is a sterile, non-pyrogenic, and single-dose container for intravenous infusion use only. It contains magnesium sulfate heptahydrate salt which is equivalent to 32.5 mEq magnesium in water for injection. The solution may contain sulfuric acid and/or sodium hydroxide for pH adjustment. The pH range of the solution is reported as 4.5 (3.5 to 6.5), and the container size is 50 mL. The manufacturer is WG Critical Care, LLC, located in Paramus, NJ, and it is made in Switzerland. The dose is mentioned in the package insert, and storage requirements indicate that it should be protected from freezing at 20° to 25°C (68° to 77°F). The lot number is also provided for manufacturing quality control purposes.*